Cannabis Science Inc (fka CBIS)

[ecmoney]

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the "Company" or "Enertopia") is very pleased to announce that Dr. Robert Melamede, Ph.D. and current President at Cannabis Science (CBIS) has joined the Advisory board of Enertopia.

"Dr. Melamede needs no introduction as he is the leader in the field of cannabis science research. We are honored to announce Robert as an important advisory board appointment from the Cannabis sector. He has un-paralleled years in cannabis research and dedication for the advancement of moving marijuana to the main stream in America. Robert will be able to apply his knowledge and industry contacts to help lead Enertopia towards its goals in the rapidly expanding legal marijuana market in North America," stated Robert McAllister, President / CEO of Enertopia.

Dr. Melamede said, "I am incredibly excited about the opportunity to help out on this rapidly growing ground floor opportunity in the legal marijuana sector. I look forward to applying my years of industry, academia and passion for life and the releasing of the healing wonders of marijuana to millions of people in North America and around the World.” Stated Dr. Robert ( Bob ) Melamede.

Mr. Shaxon, our corporate development leader at Enertopia, had this to say, "I’m very excited to be working with Bob again and building up the Enertopia team, I anticipate a great year of assisting in building Enertopia into one of the leaders in the legal marijuana sector.”

Robert McAllister, Enertopia Corporation., President & CEO said, “As I have announced before it is our intention to move Enertopia rapidly forward into what we are all witnessing today with a new era of plant based healing.” Enertopia paid a one-time $2,500 honorarium, issued 250,000 shares of restricted stock in consideration for Dr. Melamede joining our Advisory board and a further 500,000 stock options. For more information about Dr. Melamede’s background, please visit http://www.enertopia.com/s/Advisors.asp

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.